Travere Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Travere Therapeutics

20/02/2025 22:01

* Travere Therapeutics Inc  TVTX.OQ  reported a quarterly
adjusted
loss of 73 cents​​ per share for the quarter ended December 31,
higher than the same quarter last year, when the company
reported EPS of $-1.03.  The mean expectation of
fifteen analysts for the quarter was for a loss of 56 cents per
share. Wall Street expected results to range from -77 cents
to -47 cents per share.
    * Revenue rose 66% to $74.79 million from a year ago;
analysts
expected $73.34 million. 
    * Travere Therapeutics Inc's reported EPS for the quarter
was a
loss of 73 cents​.
    * The company reported a quarterly loss of $60.26 million.
    * Travere Therapeutics Inc shares had risen by 33.9% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 6.9%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 14 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Travere
Therapeutics Inc is $31.00 
This summary was machine generated from LSEG data February 20 at
10:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      -0.56          -0.73          Missed
 Sep. 30 2024      -0.68          -0.70          Missed
 Jun. 30 2024      -0.86          -0.91          Missed
 Mar. 31 2024      -0.99          -1.76          Missed